| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $71,239,603 ) (Continued on the next page) |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141357 | Molecular Mechanisms Underlying Mammalian NADPH Oxidase Activation and Regulation | 000 | 4 | NIH | 2/7/2024 | $323,100 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141694 | Chromatin of repetitive elements | 001 | 4 | NIH | 7/11/2024 | $35,900 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01GM141694 | Chromatin of repetitive elements | 000 | 4 | NIH | 4/5/2024 | $323,100 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM138293 | Computational tools for estimating cell-type-specific effects in bulk RNA-seq and spatial transcriptomics data, using reference single-cell RNA-seq datasets | 000 | 5 | NIH | 5/2/2024 | $436,750 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA264837 | Biomarkers of dasatinib response and resistance in T-cell acute lymphoblastic leukemia | 000 | 4 | NIH | 6/26/2024 | $569,213 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA245508 | Modeling Retinoblastoma Initiation Using 3D-Retinal Organoids | 000 | 5 | NIH | 4/24/2024 | $390,077 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA245301 | Regulation of collagen linearization during cancer progression and metastasis | 001 | 4 | NIH | 4/16/2024 | $20,531 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA245301 | Regulation of collagen linearization during cancer progression and metastasis | 000 | 4 | NIH | 2/22/2024 | $369,546 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA248432 | Novel Therapeutic Approaches for the Treatment of Neuroblastoma | 003 | 5 | NIH | 4/17/2024 | $1,969 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA248432 | Novel Therapeutic Approaches for the Treatment of Neuroblastoma | 002 | 5 | NIH | 4/17/2024 | $20,531 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI153138 | Robust immune tolerance conferred by Foxp3 transcriptional regulation | 001 | 4 | NIH | 5/20/2024 | $44,875 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI153138 | Robust immune tolerance conferred by Foxp3 transcriptional regulation | 000 | 4 | NIH | 12/15/2023 | $403,875 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA248432 | Novel Therapeutic Approaches for the Treatment of Neuroblastoma | 001 | 5 | NIH | 3/11/2024 | $35,491 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA248432 | Novel Therapeutic Approaches for the Treatment of Neuroblastoma | 000 | 5 | NIH | 3/8/2024 | $369,546 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K00CA234924 | Elucidating USP16 function and probing its DUB activity in Down syndrome leukemia | 000 | 6 | NIH | 1/23/2024 | $90,271 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37AI105887 | Metabolic checkpoint in dendritic cell subsets and adaptive immunity | 001 | 11 | NIH | 5/15/2024 | $45,500 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37AI105887 | Metabolic checkpoint in dendritic cell subsets and adaptive immunity | 000 | 11 | NIH | 1/26/2024 | $409,500 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08CA250418 | Hypertension Intervention to Reduce Osteonecrosis in Children with Acute Lymphoblastic Leukemia | 000 | 5 | NIH | 2/27/2024 | $224,070 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA237311 | Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy | 001 | 5 | NIH | 4/19/2024 | $20,531 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA237311 | Epigenetic Reprogramming of T cell Exhaustion To Enhance Tumor Immunotherapy | 000 | 5 | NIH | 2/22/2024 | $369,546 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA239689 | eHealth Intervention for Late Effects of Childhood Cancer | 000 | 5 | NIH | 6/11/2024 | $631,355 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI136514 | DECODING THE INTERACTIONS BETWEEN T CELL RECEPTORS AND PEPTIDE-MHC | 000 | 7 | NIH | 5/17/2024 | $867,150 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | K08DK130790 | Insights from somatic genomics lead to novel therapeutic targets in inherited bone marrow failure syndromes: Shwachman-Diamond Syndrome as a model | 001 | 4 | NIH | 6/21/2024 | $168,361 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI140761 | Transcriptional and metabolic heterogeneity in T cell differentiation | 001 | 6 | NIH | 6/11/2024 | $491,400 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R37AI044828 | Survival Function of the Fadd-Caspase-8-Flip Complex - MERIT Extension | 000 | 26 | NIH | 4/8/2024 | $455,000 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI180231 | Hybrid Antibiotics for Persistent Infections | 000 | 2 | NIH | 7/2/2024 | $842,568 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM122462 | Structure and functional mechanisms of molecular chaperones and protein kinases | 001 | 8 | NIH | 6/19/2024 | $76,430 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM122462 | Structure and functional mechanisms of molecular chaperones and protein kinases | 000 | 8 | NIH | 1/22/2024 | $687,854 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01DK111430 | Molecular Analysis of Transcriptional Enhancers in Hematopoiesis | 000 | 9 | NIH | 5/7/2024 | $468,443 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35NS097974 | Dynamic RNA-protein assemblies and neurological disease | 002 | 8 | NIH | 7/23/2024 | $0 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35NS097974 | Dynamic RNA-protein assemblies and neurological disease | 001 | 8 | NIH | 5/14/2024 | $62,825 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35NS097974 | Dynamic RNA-protein assemblies and neurological disease | 000 | 8 | NIH | 11/21/2023 | $807,750 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI124346 | Innate immune signaling and stress response | 001 | 9 | NIH | 5/28/2024 | $53,850 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI124346 | Innate immune signaling and stress response | 000 | 9 | NIH | 2/15/2024 | $484,650 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R35GM118041 | Regulation of xenobiotic receptors PXR and CAR, and CYP3A: implications in drug disposition | 000 | 9 | NIH | 3/8/2024 | $403,875 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI128756 | Bioactivities of pneumococcal cell wall in neuropathogenesis | 001 | 8 | NIH | 5/23/2024 | $45,500 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01AI128756 | Bioactivities of pneumococcal cell wall in neuropathogenesis | 000 | 8 | NIH | 1/5/2024 | $409,500 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U01CA195547 | The St. Jude Lifetime Cohort | 000 | 10 | NIH | 7/3/2024 | $1,236,790 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA194057 | Transporters and Medulloblastoma | 001 | 9 | NIH | 4/17/2024 | $20,324 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA194057 | Transporters and Medulloblastoma | 000 | 9 | NIH | 2/29/2024 | $365,852 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | T32AI106700 | Training in the Design and Development of Infectious Disease Therapeutics | 000 | 9 | NIH | 6/14/2024 | $226,658 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | UM1CA081457 | Pediatric Brain Tumor ConsortiumA multi-institutional consortium devoted to novel phase I and II clinical evaluations of experimental treatment approaches for pediatric CNS tumors. | 000 | 25 | NIH | 4/11/2024 | $3,704,144 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R01CA172152 | Role of the SWI/SNF complex in tumor suppression | 001 | 12 | NIH | 2/1/2024 | $450,446 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | R25CA023944 | PEDIATRIC ONCOLOGY EDUCATION (YEARS 38 - 42) | 001 | 40 | NIH | 5/8/2024 | $432,000 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Enhance the CCSS biospecimen resource through characterization of clonal hematopoiesis among survivors of childhood cancer | 009 | 30 | NIH | 7/8/2024 | $1,021,963 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Enhance the CCSS biospecimen resource through characterization of clonal hematopoiesis among survivors of childhood cancer | 008 | 30 | NIH | 5/23/2024 | $384,642 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Enhance the CCSS biospecimen resource through characterization of clonal hematopoiesis among survivors of childhood cancer | 007 | 30 | NIH | 5/8/2024 | $0 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Enhance the CCSS biospecimen resource through characterization of clonal hematopoiesis among survivors of childhood cancer | 006 | 30 | NIH | 4/24/2024 | $209,854 |
| 2024 | 2024 | ST JUDE CHILDREN'S RESEARCH HOSPITAL INC | 262 DANNY THOMAS PL | MEMPHIS | TN | 38105-3678 | SHELBY | USA | U24CA055727 | Enhance the CCSS biospecimen resource through characterization of clonal hematopoiesis among survivors of childhood cancer | 004 | 30 | NIH | 12/11/2023 | $3,777,365 |
|